Article info
PDFCommentary
Response
It's time for change; commentary in response to feature article by Halpin et al
- Correspondence to Dr Michael Keane, Human Psychopharmacology, Swinburne University, Hawthorn, Melbourne, Victoria 3122, Australia; mkeane{at}swin.edu.au
Citation
It's time for change; commentary in response to feature article by Halpin et al
Publication history
- Received December 21, 2013
- Accepted February 9, 2014
- First published February 28, 2014.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- Trends in clinical development timeframes for antiviral drugs launched in the UK, 1981–2014: a retrospective observational study
- Pharmacogenetics, ethical issues: review of the Nuffield Council on Bioethics Report
- Rethinking the appraisal and approval of drugs for type 2 diabetes
- Prescribing new drugs: qualitative study of influences on consultants and general practitioners
- Public sector financial support for late stage discovery of new drugs in the United States: cohort study
- Speeding new antibiotics to market: a fake fix?
- Fair, just and compassionate: A pilot for making allocation decisions for patients requesting experimental drugs outside of clinical trials
- Fitting the drug to the patient
- Decline in new drug launches: myth or reality? Retrospective observational study using 30 years of data from the UK
- Clinical Research and Drug Development in Latin America